Woman’s Research conducts clinical and molecular biology/genetic research, and collaborates with institutions across the U.S. All clinical research studies are submitted to Woman's Research and Development Council. Studies involving human subjects are referred to the Woman's Hospital Foundation Institutional Review Board for review.
Learn if you can be a part of our mission by participating in the following studies.
New Direction in Treatment for PCOS Study
This 16-week study is for women who have polycystic ovary syndrome (PCOS) and elevated blood sugar. It will test the success of a new medicine that has been found to improve abnormal glucose (sugar) levels and reduce body weight.
Thirty-six participants are needed who meet the following criteria: 18-42 years old with PCOS, have less than nine menstrual cycles per year, have elevated blood sugar (but not diabetic), nonsmoker and not pregnant or breastfeeding.
All participants will receive a 16-week supply of medication. Office visits and lab test will be included free of charge and participants will be compensated for their time. For more information, patients may contact Woman's Research at 225-231-5275 or email us.
Better Rx for Gestational Diabetes Mellitus (GDM) Study explores why one out of every three women with gestational diabetes will battle "pre-diabetes" after her baby is born. This means that blood glucose levels are higher than normal. People with pre-diabetes are at a high risk of developing diabetes. Woman’s BetteRX Moms study will compare the effectiveness of different oral medicines in treating this condition.
BetteRX Moms must meet the following criteria: English-speaking women ages 18-42, had gestational diabetes during their last pregnancy, gave birth less than a year ago and diagnosed as pre-diabetic by an oral glucose (sugar) tolerance test.
Participants will receive the following at no charge: A personalized diet and exercise plan, physician office visits, lab testing and an oral medication for 16 weeks (randomly assigned medications include Sitagliptin plus Metformin (Janumet), Metformin or a placebo.) Participants will also be compensated for their time.
Study to Prevent Diabetes in Post-Pregnancy, Overweight Women with History of Gestational Diabetes will focus on preventing the onset of diabetes in overweight women with a history of gestational diabetes who delivered less than a year ago. In a double-blind placebo trial, for the next two years, Woman's will monitor 150 women in order to determine the effectiveness of two drug combinations in stabilizing sugar and insulin levels and promoting weight loss. The medications are Metformin and Metformin in combination with Liraglutide, a long-acting glucagon-like peptide 1 (GLP-1) derivative administered once daily.
Combined Liraglutide and Metformin Therapy in Women with Previous Gestational Diabetes Mellitus will study overweight women who were diagnosed with GDM in their last pregnancy, have not returned to normal metabolic function, and remain overweight with diagnosed insulin problems. Participants must have delivered infants at Woman's Hospital and had GDM within the past year, be 18-45 years old, and meet all additional study requirements. Participants will be compensated for their time in addition to receiving free medication, clinic visits with the physician, and testing.
For more information, patients may contact Woman's Research at 225-231-5275 or email us.
LAMBS: Are you pregnant? If so, you may be eligible to participate in the LA Moms and Babies Study (LAMBS) for nutrition and growth. This research study evaluates how diet during pregnancy can benefit pregnancy and pregnancy outcome, such as your baby’s weight. Information gained from LAMBS will help us make the best nutrition and diet recommendations to pregnant women and women of child bearing ages.
You may be eligible to participate if you are :
- 18-35 years old
Benefits to participants:
- General nutrition guidelines provided during study
- Summary of infant’s growth during first year of life
- Qualified study participants will earn up to $575 over the course of approximately 80 weeks
To learn more, call 225-231-5275 or email us.
Woman's actively participates in ongoing clinical cancer research.
To learn about the most recent gynecologic cancer studies and find out if you are a candidate, please contact Ashley Marks, BSN, RN, 225-924-8215.